Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
38.79
+5.69 (17.19%)
May 20, 2024, 11:23 AM EDT - Market open

PTC Therapeutics Revenue

PTC Therapeutics had revenue of $927.56M in the twelve months ending March 31, 2024, with 20.39% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $210.12M, a -4.66% decrease year-over-year. In the year 2023, PTC Therapeutics had annual revenue of $937.82M with 34.20% growth.

Revenue (ttm)
$927.56M
Revenue Growth
+20.39%
P/S Ratio
2.74
Revenue / Employee
$932,219
Employees
995
Market Cap
2.98B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023937.82M239.02M34.20%
Dec 31, 2022698.80M160.21M29.75%
Dec 31, 2021538.59M157.83M41.45%
Dec 31, 2020380.77M73.79M24.04%
Dec 31, 2019306.98M42.25M15.96%
Dec 31, 2018264.73M70.34M36.19%
Dec 31, 2017194.39M111.69M135.04%
Dec 31, 201682.71M45.94M124.95%
Dec 31, 201536.77M11.52M45.64%
Dec 31, 201425.25M-9.45M-27.24%
Dec 31, 201334.70M750.00K2.21%
Dec 31, 201233.95M-71.47M-67.80%
Dec 31, 2011105.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
ICU Medical 2.26B
Inari Medical 520.66M
Certara 360.69M
TG Therapeutics 289.33M
Immunocore Holdings 264.25M
Intellia Therapeutics 52.60M
Merus 38.34M
Revenue Rankings

PTCT News

More News